| Authors: |
Greaney AM; Department of Biomedical Engineering, Yale University, New Haven, CT 06511, USA.; Vascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT 06511, USA., Raredon MSB; Department of Biomedical Engineering, Yale University, New Haven, CT 06511, USA.; Vascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT 06511, USA.; Medical Scientist Training Program, Yale University, New Haven, CT 06511, USA., Kochugaeva MP; Department of Biomedical Engineering, Yale University, New Haven, CT 06511, USA.; Yale Systems Biology Institute, Yale University, West Haven, CT 06516, USA., Niklason LE; Department of Biomedical Engineering, Yale University, New Haven, CT 06511, USA.; Vascular Biology and Therapeutics Program, Yale School of Medicine, New Haven, CT 06511, USA.; Department of Anesthesiology, Yale School of Medicine, New Haven, CT 06510, USA.; Humacyte Inc., Durham, NC 27713, USA., Levchenko A; Department of Biomedical Engineering, Yale University, New Haven, CT 06511, USA.; Yale Systems Biology Institute, Yale University, West Haven, CT 06516, USA. |
